Article ID Journal Published Year Pages File Type
3991679 Journal of Thoracic Oncology 2006 5 Pages PDF
Abstract
The combination of paclitaxel, carboplatin, and topotecan combined with granulocyte colony-stimulating factor support is an active and reasonably well-tolerated regimen for the treatment of extensive stage small cell lung cancer.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
Phase II Trial of Paclitaxel, Carboplatin, and Topotecan with G-CSF Support in Previously Untreated Patients with Extensive Stage Small Cell Lung Cancer: Southwest Oncology Group 9914
Authors
, , , , , , , , , , ,